msfaccess.org

• charset: utf-8
• name: description content: MSF Access works to improve access to affordable, quality medicines, vaccines, and diagnostics for the patients and communities we assist and beyond.
• name: robots content: index, follow, max-snippet:160, max-image-preview:large, max-video-preview:-1
• name: google content: qJvqPBFzd60h9oasMuqlmmw2vDNGIr0dfoD298G0A8s
• property: og:site_name content: MSF Access
• property: og:type content: webpage
• property: og:url content: https://msfaccess.org/
• property: og:title content: MSF Access (formerly Access Campaign)
• property: og:description content: What good is a breakthrough medicine, vaccine or test if the people who need it cannot afford it?
• property: og:image content: https://msfaccess.org/sites/default/files/2018-05/MSBAL_3.png
• property: fb:pages content: 149220252251
• property: fb:app_id content: 448069528975455
• name: twitter:site content: @msf_access
• name: twitter:title content: MSF Access
• name: twitter:description content: Medicines shouldn’t be a luxury
• name: twitter:image content: https://msfaccess.org/sites/default/files/2020-12/NoDossier_NoCounty_AC_Twitter%20card_2020_NoURN_1200x600px.jpg
• name: msvalidate.01 content: 01284B55A33A9AED423FC4B60D713DC8
• name: Generator content: Drupal 10 (https://www.drupal.org)
• name: MobileOptimized content: width
• name: HandheldFriendly content: true
• name: viewport content: width=device-width, initial-scale=1.0
• name: referrer content: MSF Access

• http://msfaccess.org/#main-content
• Pandemic preparedness
• Media room
• Contact
• About MSF Access
• Latest news
• Jobs
• Our work
• Diabetes
• Drug-resistant infections
• Hypertension
• Patents & intellectual property
• Pandemic prevention, preparedness and response
• Research & development
• Spotlight on: the Big Pharma double-dip
• Transparency Matters: Clinical Trials Costs
• Tuberculosis
• Vaccines
• Other work
• COVID-19
• Hepatitis C
• HIV/AIDS
• Tropical & neglected diseases
• Get involved
• Campaign success stories
• #NoMoreTears Johnson & Johnson Can you hear us?
• A Fair Shot
• Novartis 'Drop the case'
• Trans-pacific Partnership (TPP)
• Time for $5
• No Patents in a Pandemic
• Share the Tech - Save Lives
• Resources
• Press releases
• Statements
• Letters
• Opinion articles
• Feature stories
• Interviews
• Blog
• Newsletters
• Publications
• Research articles
• Topic overview pages
• Videos
• Photo stories
• Infographics
• Events
• Sign up for our newsletter
• Our campaigns
• Read more
• Europe
• http://msfaccess.org/ensuring-collective-efforts-deliver-equitable-access-through-who-pabs-system
• MSF statements at WHO Executive Board 158th session
• Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions
• MSF responds to Novo Nordisk’s discontinuation of key insulin products in EU/EEA
• MSF Statement at IGWG4
• http://msfaccess.org/how-insulin-pens-are-changing-lives-south-sudans-remote-villages
• http://msfaccess.org/discussion-antimicrobial-resistance-conflict-affected-settings
• http://msfaccess.org/msf-findings-show-who-algorithms-could-double-number-children-diagnosed-and-treated-tb
• http://msfaccess.org/statement-international-president-msf-2025-g20-health-ministers-meeting-novel-tuberculosis-vaccines
• http://msfaccess.org/msf-responds-whos-annual-global-tb-report-governments-and-donors-must-close-deadly-gap-diagnosing
• http://msfaccess.org/msf-statement-opening-session-igwg3
• http://msfaccess.org/pediatric-tb-revolutions
• http://msfaccess.org/msfs-panel-discussion-bridging-gap-securing-access-essential-tb-medicines-eu-and-eea
• Drug-resistant infections
• http://msfaccess.org/cso-open-letter-european-parliaments-committee-public-health
• Every 3 minutes, a child dies of tuberculosis
• Load More
• Read more
• Read more
• Read more
• About MSF Access
• Contact us
• Resources
• Search
• Privacy & data protection information
• [email protected]
• https://bsky.app/profile/msfaccess.org
• here

• msf.org
• The Patent Oppositions Database
• Algorithms for good!
• https://vimeo.com/328402119/749858619e
• https://vimeo.com/530716152
• https://vimeo.com/220461300
• https://x.com/msf_access
• https://www.facebook.com/MSFaccess/
• https://www.youtube.com/@MSFAccess
• https://msf-access.medium.com/
• supported internet connection
• Utiq’s privacy portal (“consenthub”)
• Utiq's privacy statement

            Domain Name: MSFACCESS.ORG
Registrar: Tucows Domains Inc.
Domain Status: active
Registry Expiry Date: 2027-05-15T13:27:49.142Z
Creation Date: 2008-05-15T13:27:49.142Z
Updated Date: 2026-04-30T07:07:17.316Z
Name Server: DARWIN.NS.CLOUDFLARE.COM
Name Server: LEAH.NS.CLOUDFLARE.COM
REGISTRAR Contact: Tucows Domains Inc.
>>> Last update of RDAP database: 2026-05-14T11:59:11Z         

			#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files
Disallow: /README.md
Disallow: /composer/Metapackage/README.txt
Disallow: /composer/Plugin/ProjectMessage/README.md
Disallow: /composer/Plugin/Scaffold/README.md
Disallow: /composer/Plugin/VendorHardening/README.txt
Disallow: /composer/Template/README.txt
Disallow: /modules/README.txt
Disallow: /sites/README.txt
Disallow: /themes/README.txt
Disallow: /web.config
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register
Disallow: /user/password
Disallow: /user/login
Disallow: /user/logout
Disallow: /media/oembed
Disallow: /*/media/oembed
# Paths (no clean URLs)
Disallow: /index.php/admin/
Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips
Disallow: /index.php/node/add/
Disallow: /index.php/search/
Disallow: /index.php/user/password
Disallow: /index.php/user/register
Disallow: /index.php/user/login
Disallow: /index.php/user/logout
Disallow: /index.php/media/oembed
Disallow: /index.php/*/media/oembed
        

Référencement technique

Référencement sur la page

Contenu et UX